Qingyi Wang
Shanghai University of Traditional Chinese Medicine(CN)
Publications by Year
Research Areas
Spine and Intervertebral Disc Pathology, COVID-19 Clinical Research Studies, Musculoskeletal pain and rehabilitation, Cancer Immunotherapy and Biomarkers, Sepsis Diagnosis and Treatment
Most-Cited Works
- → Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial(2020)170 cited
- → Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial(2021)65 cited
- → Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studies(2017)47 cited
- → What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?(2021)44 cited
- → New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication(2024)34 cited
- → Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis(2022)27 cited
- → Potential prognostic factors in progression-free survival for patients with cervical cancer(2021)26 cited
- → Long-term clinical results following Charite III lumbar total disc replacement(2017)23 cited
- → Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial(2023)16 cited
- → Microsatellite Status Detection of Colorectal Cancer: Evaluation of Inconsistency between PCR and IHC(2023)15 cited